ID: ALA4463096

Max Phase: Preclinical

Molecular Formula: C17H13BrN2

Molecular Weight: 325.21

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Brc1ccc2[nH]cc(Cc3cc4ccccc4[nH]3)c2c1

Standard InChI:  InChI=1S/C17H13BrN2/c18-13-5-6-17-15(9-13)12(10-19-17)8-14-7-11-3-1-2-4-16(11)20-14/h1-7,9-10,19-20H,8H2

Standard InChI Key:  CJPJRGOFUZQGNL-UHFFFAOYSA-N

Associated Targets(Human)

Subtilisin/kexin type 9 362 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 325.21Molecular Weight (Monoisotopic): 324.0262AlogP: 5.00#Rotatable Bonds: 2
Polar Surface Area: 31.58Molecular Species: NEUTRALHBA: 0HBD: 2
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.80CX LogD: 4.80
Aromatic Rings: 4Heavy Atoms: 20QED Weighted: 0.52Np Likeness Score: -0.52

References

1. Winston-McPherson GN, Xie H, Yang K, Li X, Shu D, Tang W..  (2019)  Discovery of 2,3'-diindolylmethanes as a novel class of PCSK9 modulators.,  29  (16): [PMID:31227343] [10.1016/j.bmcl.2019.06.014]

Source